GRANULES INDIA
Back to Balance Sheet
|
GRANULES INDIA Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹6,185 Cr | ₹5,484 Cr | ₹4,903 Cr | ₹4,512 Cr | ₹3,713 Cr |
What is the latest Total Liabilities ratio of GRANULES INDIA ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹6,185 Cr |
| Mar2024 | ₹5,484 Cr |
| Mar2023 | ₹4,903 Cr |
| Mar2022 | ₹4,512 Cr |
| Mar2021 | ₹3,713 Cr |
How is Total Liabilities of GRANULES INDIA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹6,185 Cr | 12.78 | |
| Mar2024 | ₹5,484 Cr | 11.84 | |
| Mar2023 | ₹4,903 Cr | 8.68 | |
| Mar2022 | ₹4,512 Cr | 21.52 | |
| Mar2021 | ₹3,713 Cr | - | |
Compare Total Liabilities of peers of GRANULES INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GRANULES INDIA | ₹14,627.6 Cr | 3.8% | 6.2% | 12.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹428,185.0 Cr | 3% | 9.5% | 3.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,766.0 Cr | 1.7% | 3.1% | 5.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,923.0 Cr | 4.7% | 11.7% | 41.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,081.0 Cr | 2.1% | 6.7% | 11.6% | Stock Analytics | |
| CIPLA | ₹109,680.0 Cr | 1.3% | 1.3% | -9.4% | Stock Analytics | |
GRANULES INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GRANULES INDIA | 3.8% |
6.2% |
12.8% |
| SENSEX | -0.3% |
-0.1% |
8.3% |
You may also like the below Video Courses